Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on VX 960. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103342656B reveals a safer Telaprevir intermediate route. Eliminate hazardous reagents for significant cost reduction in API manufacturing and supply reliability.
Novel route for VX-960 intermediate via cyanation and resolution. High purity, mild conditions, cost-effective manufacturing for global supply chains.
Novel VX-960 synthesis avoids low-yield oxidation. Enhances supply chain reliability and cost efficiency for hepatitis C treatment manufacturing.